This investigational peptide combination brings together three compounds that influence growth hormone pathways. CJC-1295 and Ipamorelin stimulate growth hormone release through different mechanisms, while Tesamorelin is a growth hormone–releasing hormone analogue studied for its effects on visceral fat and metabolic health.